Our approach is to be highly specialized in terms of areas, healthtech and fintech (see more below), and in terms of stage, pre product and pre market, and highly concentrated working with few companies at a time. This allows us to do the job of earliest stage investing, and company building, as we think it should be done.

If we agree on “the why” and “the who”, we are ok with taking the risk together on “the what” and “the how”. This can happen either as angel ticket or pre-seed investment, or by one of us being part of incubating a company.

Early stage investing has changed a lot - and not for the better. Party rounds, spray & pray, extra-large funds writing early “optionality” checks with limited ability to engage. Nobody seems to want to, or know how to, do the job anymore. The focus is predominantly on “having access” and “gaining exposure”.

We believe in a more deliberate approach where the best way to invest in, and help build, highly valuable and category-defining companies is to identify market opportunities where great companies can be built, invest as early as possible in outstanding founders, and put in the time to help them get from zero to traction. We call it investing like Founders, not funders.